Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Daiichi Sankyo, Eli Lilly Launch Prasugrel in UK
April 20, 2009
- Takara Bio Obtains License from Kyoto Univ.
April 20, 2009
- Eli Lilly Licenses Cialis to Nippon Shinyaku
April 20, 2009
- GE, Intel Ally in Home Health Technologies
April 20, 2009
- Otsuka, BMS Extend Agreement on Abilify, Embark on Global Oncology Collaboration
April 20, 2009
- Olympus Releases Biliary Stent Jointly with Medinol
April 20, 2009
- Pfizer Aims to Become Market Leader for Macrolides with Zithromac SR
April 20, 2009
- AMDD Inaugurated with Dr H. Wang as President
April 20, 2009
- Hisamitsu: Both Sales and Profits Up 8th Year in a Row
April 20, 2009
- Agilent Technologies Launch SurePrint G3 Microarray
April 20, 2009
- Merck Serono: Gonalef Subcutaneous Injection Pen
April 20, 2009
- Eisai Licenses Out Gliadel Wafer to Nobelpharma
April 20, 2009
- BUSINESS NEWS IN BRIEF
April 20, 2009
- Asahi Kasei to Globally Develop Business for Evaheart
April 20, 2009
- Shiro Kondo Recognized as Teijin Group Fellow for His Contribution to the Development of Febuxostat
April 20, 2009
- R&D NEWS IN BRIEF
April 20, 2009
- OHARA to Improve Tablet Distinguishability by ID Printing on Both Sides of Tablet
April 20, 2009
- Leadership Changes at KYORIN
April 20, 2009
- JPDSC to Construct PGx Database for the Japanese
April 20, 2009
- GENERICS NEWS IN BRIEF
April 20, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…